James Mc Leod, MD

James Mc Leod, MD
Chief Medical Officer, USA
James Mc Leod is a physician scientist and pharmaceutical executive with over 25
years of experience spanning preclinical and the phases of clinical development.
Prior to joining InxMed, he was Chief Medical Officer and Senior VP at Galleon
Pharmaceuticals and a consultant to small biotechnology companies and
medical research foundations. He has headed the Experimental Medicine group
at Merck Research Laboratories and the Early Clinical Research and Experimental
Medicine group at the Schering-Plough Research Institute (SPRI). He joined
SPRI from Novartis in 2004, where he headed the Clinical Pharmacology,
Experimental Clinical Pharmacology and Translational Medicine groups. He has
extensive clinical development experience with individual or group leadership of
24 new drug approvals globally spanning all major therapeutic areas including
gastroenterology and oncology medications. James has degrees in Biomedical
and Chemical Engineering (Rensselaer Polytechnic Institute) and Medicine
(University of Connecticut) was medically boarded in internal medicine and
endocrinology and metabolism. He has been a fellow in the Endocrinology &
Metabolism and Human Genetics and has held faculty positions at the University
of Pennsylvania and Northwestern University medical schools. He has been a
member of ICH working groups and has co-chaired PhRMA and IQ Consortium
innovation initiatives. He is a past chair of the PhRMA Clinical Pharmacology
Technical Group.